Posaconazole and Guaifenesin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Posaconazole (posaconazole) and Guaifenesin (guaifenesin). Common drug interactions include death among females and death among males.
The phase IV clinical study analyzes what interactions people have when they take Posaconazole and Guaifenesin. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.
What is Posaconazole?
Posaconazole has active ingredients of posaconazole. eHealthMe is studying from 9,475 Posaconazole users. Check the latest studies of Posaconazole.
What is Guaifenesin?
Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.
36 people who take Posaconazole and Guaifenesin together, and have interactions are studied.

What are the common drug interactions of Posaconazole and Guaifenesin, by gender? *:
female:
- Death
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Febrile neutropenia (fever with reduced white blood cells)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Fluid overload (too much fluid in the blood)
- Abdominal pain upper
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Pleural effusion (water on the lungs)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
male:
- Death
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Erythema (redness of the skin)
- Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
- Gout (uric acid crystals building up in the body)
- Haematoma (collection of blood outside the blood vessels)
- Haemorrhage (bleeding)
- Headache (pain in head)
- Hypertension (high blood pressure)
- Hypokalaemia (low potassium)
What are the common drug interactions of Posaconazole and Guaifenesin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Bone marrow failure
- Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
30-39:
- Decreased appetite
- Headache (pain in head)
- Pyrexia (fever)
- Red blood cell count decreased
- White blood cell count decreased
40-49:
- Abdominal pain upper
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Pleural effusion (water on the lungs)
- Lymphadenopathy (disease or enlargement of lymph nodes)
50-59:
- Death
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Arthralgia (joint pain)
- Back pain
- Blood creatinine increased
- Brain abscess
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Electric shock
- Erythema (redness of the skin)
60+:
- Asthenia (weakness)
- Dehydration (dryness resulting from the removal of water)
- Chronic lymphocytic leukaemia transformation (white blood cell cancer changes in fast growing cancer in lymph node)
- Fatigue (feeling of tiredness)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Hospitalisation
- Infection
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Syncope (loss of consciousness with an inability to maintain postural tone)
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 21 people, 58.33%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 11.11%
- Pain: 4 people, 11.11%
- Nausea (feeling of having an urge to vomit): 4 people, 11.11%
- Nausea And Vomiting: 3 people, 8.33%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 8.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.33%
- Fever: 3 people, 8.33%
- Diarrhea: 3 people, 8.33%
- Insomnia (sleeplessness): 2 people, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Posaconazole and Guaifenesin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Posaconazole (9,475 reports)
- Guaifenesin (12,106 reports)
Browse all drug interactions of Posaconazole and Guaifenesin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Posaconazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Guaifenesin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Posaconazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Guaifenesin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on posaconazole and guaifenesin (the active ingredients of Posaconazole and Guaifenesin, respectively), and Posaconazole and Guaifenesin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Pomalidomide and Doxorubicin Hydrochloride - 8 seconds ago
- Could Palonosetron Hydrochloride cause Disease Progression? - 9 seconds ago
- Could Lisinopril cause Spontaneous Penile Erection? - 14 seconds ago
- Could Seng cause Diabetes? - 15 seconds ago
- Could Profen cause Vitamin B12 Increased? - 21 seconds ago
- Drug interactions of Brinzolamide and Escitalopram - 24 seconds ago
- Could Lamictal cause Drug Abuse And Dependence? - 27 seconds ago
- Drug interactions of Enulose and Diphen - 39 seconds ago
- Could Vistaril cause Suicidal Ideation? - 46 seconds ago
- Drug interactions of Peg-Intron and Lipitor - 47 seconds ago